Table 4 Diagnostic accuracy
Gene | Overall sensitivity (n = 40) % | Early tumors sensitivity (n = 22) %a | Locally advanced tumors sensitivity (n = 18) %b | Overall specificity (n = 40) % | Overall accuracy (n = 80) % |
|---|---|---|---|---|---|
RARB | |||||
Rate (95 % CI) | 30/40 75 (59–87) | 15/22 68 (49–87) | 15/18 83 (66–100) | 40/40 100 (91–100) | 70/80 88 (78–94) |
GSTP1 | |||||
Rate (95 % CI) | 28/40 70 (53–83) | 14/22 64 (44–84) | 14/18 78 (59–97) | 37/40 93 (80–98) | 65/80 81 (71–89) |
CCND2 | |||||
Rate (95 % CI) | 27/40 68 (51–81) | 12/22 55 (34–76) | 15/18 83 (66–100) | 37/40 93 (80–98) | 64/80 80 (70–88) |
RASSF1 | Â | Â | Â | Â | Â |
Rate (95 % CI) | 35/40 88 (73–96) | 18/22 82 (66–98) | 17/18 94 (83–100) | 33/40 83 (67–93) | 68/80 85 (75–92) |
SCGB3A1 | |||||
Rate (95 % CI) | 38/40 95 (83–99) | 21/22 95 (86–100) | 17/18 94 (83–100) | 34/40 85 (70–94) | 72/80 90 (81–96) |